Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses

Trends in Immunology

Volumn 23, Issue 11, 2002, Pages 509-512

  Beg, Amer A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; LIGAND; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTATION; ARTICLE; CELL DEATH; CELL MATURATION; CONTAMINATION; DENDRITIC CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNITY; IN VIVO STUDY; INFLAMMATION; MICROORGANISM; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FAMILY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0036839577     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)02317-7     Document Type: Review

References (45)

1. Janeway C.A. Jr, Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20:2002;197-216.
2. Akira S., et al. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
3. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787.
4. Ghosh S., et al. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
5. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
6. Medzhitov R., et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
7. Poltorak A., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
8. Takeuchi O., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
9. O'Neill L.A. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol. 23:2002;296-300.
10. Fitzgerald K.A., et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
11. Horng T., et al. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:2001;835-841.
12. Xu Y., et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 408:2000;111-115.
13. Li M., et al. An essential role of the NF-κB/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166:2001;7128-7135.
14. Ohashi K., et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164:2000;558-561.
15. Vabulas R.M., et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277:2002;15107-15112.
16. Termeer C., et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195:2002;99-111.
17. Vabulas R.M., et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277:2002;20847-20853.
18. Asea A., et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277:2002;15028-15034.
19. Guillot L., et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:2002;5989-5992.
20. Rathmell J.C., Thompson C.B. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17:1999;781-828.
21. Searle J., et al. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol. Annu. 17:1982;229-259.
22. Basu S., et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12:2000;1539-1546.
23. Gallucci S., et al. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1999;1249-1255.
24. Sauter B., et al. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:2000;423-434.
25. Srivastava P.K. Immunotherapy of human cancer: lessons from mice. Nat. Immunol. 1:2000;363-366.
26. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20:2002;395-425.
27. Basu S., et al. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. 14:2001;303-313.
28. Somersan S., et al. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167:2001;4844-4852.
29. Binder R.J., et al. CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1:2000;151-155.
30. Underhill D.M., et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 401:1999;811-815.
31. Scaffidi P., et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:2002;191-195.
32. Ouaaz F., et al. Dendritic cell development and survival require distinct NF-κB subunits. Immunity. 16:2002;257-270.
33. Triantafilou M., Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23:2002;301-304.
34. Wallin R.P., et al. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23:2002;130-135.
35. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
36. Matzinger P. The danger model: a renewed sense of self. Science. 296:2002;301-305.
37. Medzhitov R., Janeway C.A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science. 296:2002;298-300.
38. + T cells. Nat. Immunol. 2:2001;1010-1017.
39. Blankenstein T., Schuler T. Cross-priming versus cross-tolerance: are two signals enough? Trends Immunol. 23:2002;171-173.
40. Berwin B., et al. Virally induced lytic cell death elicits the release of immunogenic GRP94/gp96. J. Biol. Chem. 276:2001;21083-21088.
41. Alexopoulou L., et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 413:2001;732-738.
42. Leadbetter E.A., et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:2002;603-607.
43. Okamura Y., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:2001;10229-10233.
44. Smiley S.T., et al. Fibrinogen stimulates macrophage chemokine secretion though Toll-like receptor 4. J. Immunol. 167:2001;2887-2894.
45. Johnson G.B., et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168:2002;5233-5239.